Page of

Thyroid cancer and radioiodine therapy: Thyroid cancer and radioiodine therapy Expert commentary Nicola Dallas Expert commentary Nicola Dallas 

Thyroid cancer and radioiodine therapy: Thyroid cancer and radioiodine therapy Expert commentary Nicola Dallas Expert commentary Nicola Dallas
Chapter:
Thyroid cancer and radioiodine therapy: Expert commentary Nicola Dallas
Source:
Challenging Concepts in Oncology
Author(s):

David Woolf

DOI:
10.1093/med/9780199688883.003.0021

Thyroid cancer is the commonest malignancy to affect the endocrine system, with 80% of lesions being papillary. The incidence rates of this malignancy continue to rise significantly, whilst cure rates are increasing and relapse-free survival is amongst the highest of any solid cancer. Treatment is multidisciplinary, involving thyroid surgeons, clinical oncologists, and endocrinologists. For the majority of patients, the treatment pathway will involve local surgery, with either a lobectomy or a total thyroidectomy, and radioactive iodine therapy, although significant controversies remain and prospective data are lacking. This chapter reviews a patient case history and explores aspects of the management, including: the choice of surgical approach and whether a lymph node dissection is appropriate; the role of radioactive iodine; the preparation for, and complications of, therapy; and follow-up schedules.

Sign In

Copyright © 2020. All rights reserved.